Abdominal Delivery Clinical Trial
Official title:
Closure Versus Non Closure of Subcutaneous Tissue After Cesarean Section in Diabetic Patients
Verified date | November 2016 |
Source | Ain Shams University |
Contact | n/a |
Is FDA regulated | No |
Health authority | |
Study type | Interventional |
The aim of this study is to determine the surgical site infection rate and the patient's satisfaction for closure of subcutaneous tissue versus non closure of subcutaneous tissue after cesarean delivery in women with diabetes mellitus.
Status | Completed |
Enrollment | 136 |
Est. completion date | October 2016 |
Est. primary completion date | September 2016 |
Accepts healthy volunteers | Accepts Healthy Volunteers |
Gender | Female |
Age group | 18 Years to 45 Years |
Eligibility |
Inclusion Criteria: 1. Pregnant women in childbearing period (18-45 years). 2. Women planned for elective cesarean section. 3. Pregnant women with gestational diabetes according to medical records. Exclusion Criteria: 1. Hemoglobin less than 10g/dl. 2. Intra operative events that may themselves predispose to postoperative infection (e.g. operative time more than 90 minutes). 3. Rupture of membrane more than 12 hours. 4. Receive corticosteroid medications. 5. Immunosuppressive disease or Auto immune disease. 6. Concurrent infection (e.g. signs of pyelonephritis, chest infection). 7. Previous history of two C.S. 8. Previous laparotomy other than C.S. |
Country | Name | City | State |
---|---|---|---|
n/a |
Lead Sponsor | Collaborator |
---|---|
Ain Shams University |
Type | Measure | Description | Time frame | Safety issue |
---|---|---|---|---|
Primary | Number of participants with surgical site infection | Surgical site infection: including the following manifestations: Collection; inflammatory signs (pain, tenderness, edema, redness); dehiscence (wound separation) or positive culture. | 9 months | |
Secondary | Number of participants with wound seroma | wound seroma, superficial wound breakdown (defined as skin and/or subcutaneous dehiscence with intact fascial layer). | month | |
Secondary | Number of participants with postoperative pain | Postoperative pain (judged after 24 hours, through visual analogue scale (VAS); with 0 meaning no pain, and 10 meaning the worst pain). | 24 hours | |
Secondary | Number of participants with postoperative fever | postoperative fever (defined as temperature more than thirty eight degree, 48 hours postoperative. | 48 hours | |
Secondary | Number of participants with cosmetic wound | Is cosmetic wound outcome for one month postoperative good or no? | 1 month |
Status | Clinical Trial | Phase | |
---|---|---|---|
Completed |
NCT01078519 -
Combined Anesthesia for Labor and Maternal Temperature
|
Phase 3 |